Sequenom Announces Distribution Agreement with Invitrogen for South and Central America
News May 01, 2008
Sequenom, Inc. has announced that it has entered into an agreement with Invitrogen Corporation under which Invitrogen will be the exclusive distributor for Sequenom's MassARRAY® systems and consumable products in Central and South America. Financial terms of the agreement were not disclosed.
"Among our top priorities is expanding our geographic reach and this agreement provides us with an entree into Central and South America, regions where we see a substantial opportunity but have had little exposure," said Sequenom's Senior Vice President, Sales & Marketing Michael Monko. "We are set to enter these regions utilizing the substantial resources available through Invitrogen and are pleased to be working with Invitrogen's first-rate sales team."
Separately, Sequenom announced the sale of its first MassARRAY system in South America. The system was sold to a sugarcane consortium to be used in biofuel research and development. Brazil is a leader in this area, producing the cheapest ethanol in the world. Sugarcane is a highly efficient raw material for the production of ethanol and is available in abundance in Brazil. Sequenom's technology will be used as part of an effort to engineer an even more productive line of sugarcane for ethanol production, the company has said.
Cell-weighing Method Could Help Doctors Choose Cancer DrugsNews
Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.READ MORE
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE